SLS
SLS
US81642T2096
SELLAS Life Sciences Group, Inc
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
28.274.000 31.513.000
10.3%
Operating Income -28.274.000 -31.513.000
10.3%
Pretax Income -26.863.000 -30.881.000
13.0%
Net Income Common Stockholders -26.863.000 -30.881.000
13.0%
-- --
--
-- --
--
ende